The health-care team, including all GPs and nurses and the patient's
family member(s), also received one MI intervention session following
the same procedure as for patients. The following issues were discussed
separately between health-care providers and patients' family
members: the importance of medication adherence in patients, monitoring
medication use among patient, the importance of patients–doctor
collaboration in developing treatment regimes, allowing patients
to describe actual drug taking behavior, and making drug regimens
less complex, whenever possible.